| __timestamp | AstraZeneca PLC | Bausch Health Companies Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5579000000 | 246000000 |
| Thursday, January 1, 2015 | 5997000000 | 582800000 |
| Friday, January 1, 2016 | 5890000000 | 455000000 |
| Sunday, January 1, 2017 | 5757000000 | 366000000 |
| Monday, January 1, 2018 | 5932000000 | 414000000 |
| Tuesday, January 1, 2019 | 5958000000 | 471000000 |
| Wednesday, January 1, 2020 | 5991000000 | 452000000 |
| Friday, January 1, 2021 | 9736000000 | 465000000 |
| Saturday, January 1, 2022 | 9762000000 | 529000000 |
| Sunday, January 1, 2023 | 10935000000 | 604000000 |
| Monday, January 1, 2024 | 13583000000 |
Cracking the code
In the ever-evolving world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, AstraZeneca PLC has consistently outpaced Bausch Health Companies Inc. in R&D investment. From 2014 to 2023, AstraZeneca's R&D expenses surged by nearly 96%, reaching a peak in 2023. In contrast, Bausch Health's R&D spending grew by approximately 146% over the same period, yet remained significantly lower in absolute terms.
AstraZeneca's strategic focus on innovation is evident, with its R&D spending in 2023 being nearly 18 times that of Bausch Health. This disparity highlights AstraZeneca's robust pipeline and commitment to groundbreaking therapies. As the pharmaceutical landscape continues to shift, these investments will likely play a pivotal role in shaping the future of healthcare.
Research and Development Investment: Eli Lilly and Company vs Bausch Health Companies Inc.
R&D Spending Showdown: AstraZeneca PLC vs CymaBay Therapeutics, Inc.
AstraZeneca PLC or Soleno Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Investment: Sanofi vs Bausch Health Companies Inc.
Regeneron Pharmaceuticals, Inc. or Bausch Health Companies Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for argenx SE and Bausch Health Companies Inc.
Research and Development Investment: Teva Pharmaceutical Industries Limited vs Bausch Health Companies Inc.
R&D Spending Showdown: Viking Therapeutics, Inc. vs Bausch Health Companies Inc.
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
Analyzing R&D Budgets: Veracyte, Inc. vs Bausch Health Companies Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Bausch Health Companies Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Bausch Health Companies Inc. and Amphastar Pharmaceuticals, Inc.